GET THE APP

Persisting Challenges in Prevention, Management and Prediction of Prognosis in Cervical Cancer
..

Journal of Oncology Translational Research

ISSN: 2476-2261

Open Access

Review Article - (2024) Volume 10, Issue 2

Persisting Challenges in Prevention, Management and Prediction of Prognosis in Cervical Cancer

Masood F*
*Correspondence: Masood F, Cancer, COMSATS University, Pakistan, Email:
Cancer, COMSATS University, Pakistan

, DOI: 10.37421/2476-2261.2024.10.261
Citation:

Chhabra S (2019) Persisting Challenges in Prevention, Management and Prediction of Prognosis in Cervical Cancer . J Oncol Transl Res 5:134.


Copyright:

�??�?�© 2019 Chhabra S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction: It is possible to prevent mortality due to cervical cancer by appropriate and timely therapy. But it continues to be a major contributor of cancer related deaths globally because of failure in prevention, early detection and timely, appropriate therapy.
Objectives: Objective was to collect information about persisting challenges in management, prevention, prediction of prognosis of cervical cancer.
Methodology: A Simple review was done by using Up-to-date, ERMED CONSORTIUM, Cochrane Library, Delnet, MedIND to get information from available studies and reviews related to prevention, management, prediction of prognosis in cervical cancer and personal experiences were added.
Results: Usually, management of cervical cancer is as per age, parity, stage of cancer, associated disorders. It may be conservative or aggressive multimodality therapy. However after planned therapy outcome is not always as per expectations. Answers need research. Nearly 20% of women with cervical cancer die within the first year of diagnosis. Research continues about factors which affect outcome and recurrence after surgery, radiotherapy, chemoradiotherapy, and differences in efficacy of surgery, chemotherapy, radiotherapy. Despite significant developments in management, results seem to be far from optimal. Over years there has been no demonstrable reduction in the incidence of cervical cancer and deaths due to cervical cancer. More than 50% of women diagnosed with cervical cancer are younger than 50 years, so the quality of life is becoming a challenge. Sometimes extensive surgeries like complete or anterior or posterior exenteration might give satisfaction to treating surgeon but what matters is survival with quality. It is not possible to predict the prognosis and know the best therapy for recurrent disease. In developing countries lack of awareness about prevention, geographical, economic inaccessibility, poor quality services, lack of support from families are barriers to early diagnosis and also safe therapy. A lot of more research seems to be necessary for the best therapy.
Conclusion: In spite of being almost preventable cancer mortality due to cervical cancer continues to be high. At present, it is mostly not possible to predict prognosis. Appropriate management needs more research and a lot needs to be researched about prognosis too.

Introduction

Different mechanisms in cancer cells become proof against one or a lot of chemotherapeutics is thought as multidrug resistance (MDR) that hinders therapy effectiveness. Potential factors for MDR includes increased drug detoxification, faded drug uptake, increased intracellular nucleophiles levels, increased repair of drug induced DNA injury, over expression of drug transporter like P-glycoprotein(P-gp), multidrug resistance-associated proteins (MRP1,MRP2), and carcinoma resistance supermolecule (BCRP). New chemotherapeutical drug delivery systems are developed to combat drug resistance and multidrug resistance. Nanogel ar getting used to deliver medicine a lot of effectively in cancer therapy. These novel applications and techniques include: Nanogels for loading siRNA. this can be atiny low officious RNA (siRNA) may be a category of double-stranded RNA molecules consisting of 21â??23 nucleotides, concerned in inhibition of supermolecule synthesis encoded by the traveler RNAs.
arrow_upward arrow_upward